8-124539144-A-G

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_005005.3(NDUFB9):​c.-43A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00517 in 1,613,300 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0041 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0053 ( 30 hom. )

Consequence

NDUFB9
NM_005005.3 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.401

Publications

1 publications found
Variant links:
Genes affected
NDUFB9 (HGNC:7704): (NADH:ubiquinone oxidoreductase subunit B9) The protein encoded by this gene is a subunit of the mitochondrial oxidative phosphorylation complex I (nicotinamide adenine dinucleotide: ubiquinone oxidoreductase). Complex I is localized to the inner mitochondrial membrane and functions to dehydrogenate nicotinamide adenine dinucleotide and to shuttle electrons to coenzyme Q. Complex I deficiency is the most common defect found in oxidative phosphorylation disorders and results in a range of conditions, including lethal neonatal disease, hypertrophic cardiomyopathy, liver disease, and adult-onset neurodegenerative disorders. Pseudogenes of this gene are found on chromosomes five, seven and eight. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
TATDN1 (HGNC:24220): (TatD DNase domain containing 1) Predicted to enable 3'-5'-exodeoxyribonuclease activity. Predicted to be involved in DNA metabolic process and nucleic acid phosphodiester bond hydrolysis. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 8-124539144-A-G is Benign according to our data. Variant chr8-124539144-A-G is described in ClinVar as [Benign]. Clinvar id is 138470.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 30 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFB9NM_005005.3 linkc.-43A>G 5_prime_UTR_variant Exon 1 of 4 ENST00000276689.8 NP_004996.1 Q9Y6M9
TATDN1NM_032026.4 linkc.-98T>C upstream_gene_variant ENST00000276692.11 NP_114415.1 Q6P1N9-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFB9ENST00000276689.8 linkc.-43A>G 5_prime_UTR_variant Exon 1 of 4 1 NM_005005.3 ENSP00000276689.3 Q9Y6M9
TATDN1ENST00000276692.11 linkc.-98T>C upstream_gene_variant 1 NM_032026.4 ENSP00000276692.6 Q6P1N9-1

Frequencies

GnomAD3 genomes
AF:
0.00413
AC:
629
AN:
152264
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00265
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00478
Gnomad ASJ
AF:
0.0167
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.000376
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00529
Gnomad OTH
AF:
0.00862
GnomAD2 exomes
AF:
0.00440
AC:
1103
AN:
250630
AF XY:
0.00433
show subpopulations
Gnomad AFR exome
AF:
0.00156
Gnomad AMR exome
AF:
0.00356
Gnomad ASJ exome
AF:
0.0187
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000416
Gnomad NFE exome
AF:
0.00593
Gnomad OTH exome
AF:
0.00458
GnomAD4 exome
AF:
0.00528
AC:
7712
AN:
1460918
Hom.:
30
Cov.:
32
AF XY:
0.00518
AC XY:
3767
AN XY:
726794
show subpopulations
African (AFR)
AF:
0.00212
AC:
71
AN:
33464
American (AMR)
AF:
0.00380
AC:
170
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.0209
AC:
547
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00206
AC:
178
AN:
86236
European-Finnish (FIN)
AF:
0.000487
AC:
26
AN:
53394
Middle Eastern (MID)
AF:
0.00920
AC:
53
AN:
5764
European-Non Finnish (NFE)
AF:
0.00566
AC:
6284
AN:
1111178
Other (OTH)
AF:
0.00634
AC:
383
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
455
910
1366
1821
2276
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
238
476
714
952
1190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00413
AC:
629
AN:
152382
Hom.:
1
Cov.:
33
AF XY:
0.00370
AC XY:
276
AN XY:
74520
show subpopulations
African (AFR)
AF:
0.00264
AC:
110
AN:
41596
American (AMR)
AF:
0.00477
AC:
73
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
58
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4830
European-Finnish (FIN)
AF:
0.000376
AC:
4
AN:
10632
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00529
AC:
360
AN:
68044
Other (OTH)
AF:
0.00853
AC:
18
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
32
64
95
127
159
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00610
Hom.:
1
Bravo
AF:
0.00449
Asia WGS
AF:
0.00173
AC:
6
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Dec 02, 2013
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
6.1
DANN
Benign
0.63
PhyloP100
-0.40
PromoterAI
0.11
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140365193; hg19: chr8-125551385; API